Spinomax XRT Introduced as Long-Term Mosquito Control Solution in High-Risk Regions
Parkers Pharma launches 180-day larvicide tablet with extended-release Spinosad to support disease prevention in endemic areas. Manchester, UK. May 20th 2025 – Parkers Pharma has announced the introduction of Spinomax XRT, a 180-day extended-release larvicide tablet formulated with 6.25% Spinosad. The technology offers an evidence-based solution for mosquito control in
20/05/2025